Delivery Order SPE2DB20D1110-SPE2DB25FK32T
- Not listed
- The Defense Logistics Agency awarded a $14,922.01 delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 (100 tablets) on September 12, 2025, with a completion date of September 15, 2025. This is a firm fixed price order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets (100-count units) with a ceiling value of $6,804.82. This is a firm fixed-price delivery order under a competitive, non-set-aside procurement. The order has an ultimate completion date of September 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Atovaquone-Proguanil 250-100 tablets in a quantity of 100 units, with a ceiling value of $1,343.16. This contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 25, 2025, and represents a non-competitive set-aside transaction. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,244.44 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100mg in quantities of 100 tablets. This competitively awarded, firm fixed-price delivery order was issued on August 13, 2025, with an ultimate completion date of August 14, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets (100 count) with a contract ceiling value of $3,665.97. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The ultimate completion date is set for May 21, 2025, and performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $7,195.23 delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 100 count tablets, with performance through May 14, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a direct pharmaceutical supply delivery under AmerisourceBergen's existing relationship with DLA. The place of performance is located in Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters, where the...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets in a quantity of 100 units. This is a firm fixed-price delivery order valued at $10,073.70 with an ultimate completion date of August 15, 2025. The contract is not set-aside and was competitively awarded. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, the corporate headquarters...
- The Defense Logistics Agency awarded a $4,599.31 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets in quantities of 100. This is a firm fixed-price delivery order with an ultimate completion date of July 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation and was competitively awarded. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a $20,147.40 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Atovaquone-Proguanil 250-100mg in quantities of 100 tablets. The contract utilizes firm fixed price pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,268.08 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100mg tablets (100-count package) on August 6, 2025, with completion targeted for August 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB25FK32TDelivery Order
The Defense Logistics Agency awarded a $6,156.15 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets (100 count). This is a firm fixed-price delivery order with an ultimate completion date of August 8, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. Atovaquone-Proguanil is an antimalarial medication commonly used for malaria prophylaxis and treatment in military and federal healthcare settings, making this delivery order representative of the specialized pharmaceutical commodities provided under the prime vendor contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 8/7/25 |